DaVita Earnings
NYSE: DVAHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$3.78
DaVita earnings summary
DaVita is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $3.78. In its most recent report on Aug 4, 2026 (Q2 2026), DVA posted EPS of $4.02. Revenue for the quarter was $3.55 billion.
Quarterly EPS is up 55.8% from the same quarter a year earlier. Across the last 16 reports, DVA shares moved an average of 4.4% (in either direction) in the first trading session after results, rising 11 times and falling 5 times.
Summary generated from market data by MetaCap's automated system. Methodology
DVA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $4.02 | — | -2.0% |
| May 5, 2026 | — | $2.87 | — | +0.5% |
| Feb 11, 2026 | — | $3.22 | — | +1.2% |
| Oct 29, 2025 | — | $2.04 | — | +3.9% |
| Aug 5, 2025 | — | $2.58 | — | +4.5% |
| May 12, 2025 | — | $2.00 | — | -5.0% |
| Feb 13, 2025 | — | $3.08 | — | -9.5% |
| Oct 29, 2024 | — | $2.50 | — | +5.7% |
| Aug 6, 2024 | — | $2.50 | — | +7.1% |
| May 2, 2024 | — | $2.65 | — | +2.3% |
| Feb 14, 2024 | — | $1.64 | — | +2.5% |
| Nov 7, 2023 | — | $2.62 | — | +15.9% |
| Aug 3, 2023 | — | $1.91 | — | -0.4% |
| May 8, 2023 | — | $1.25 | — | +7.1% |
| Feb 22, 2023 | — | $0.81 | — | -0.4% |
| Oct 31, 2022 | — | $1.13 | — | +2.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.